The device, which is delivered transapically, represents an option for very sick patients who previously have had none.

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.

The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.

“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...